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Abstract. There is an abundance of information about the genetic basis,
physiological and molecular mechanisms of bacterial pathogenesis. In contrast,
relatively little is known about population dynamic processes, by which bacteria
colonize hosts and invade tissues and cells and thereby cause disease. In an article
published in 1978, Moxon and Murphy presented evidence that, when inoculated
intranasally with a mixture streptomycin sensitive and resistant (SmS and SmR) and
otherwise isogenic stains of Haemophilus influenzae type b (Hib), neonatal rats develop
a bacteremic infection that often is dominated by only one strain, SmS or SmR. After
rulling out other possibilities through years of related experiments, the field seems
to have settled on a plausible explanation for this phenomenon: the first bacterium
to invade the host activates the host immune response that ‘shuts the door’ on the
second invading strain. To explore this hypothesis in a necessarily quantitative way,
we modeled this process with a set of mixed stochastic and deterministic differential
equations. Our analysis of the properties of this model with realistic parameters
suggests that this hypothesis cannot explain the experimental results of Moxon
and Murphy, and in particular the observed relationship between the frequency of
different types of blood infections (bacteremias) and the inoculum size. We propose
modifications to the model that come closer to explaining these data. However, the
modified and better fitting model contradicts the common theory of independent action
of individual bacteria in establishing infections. We discuss the implications of these
results.
Keywords: bacterial infection, single−variant bottleneck, phenotypic switching,
stochastic processes.
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1. Introduction
Before the Hib (Haemophilus influenzae type b) conjugate vaccine was developed and
taken into routine use in the U. S., H. influenzae was the leading cause of bacterial
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meningitis in children under the age of five [1]. At the same time, bacterial meningitis
had high mortality and serious sequela, including deafness, blindness and mental
retardation. Even today, at least in part because of the lack of vaccines, in the
developing world the mortality rate from H. influenzae infections is substantial, with
case mortalities approaching 14.3% [1].
In 1974 Richard Moxon and colleagues developed a neonatal rat model to study
the pathogenesis of Haemophilus influenzae [2]. They presented evidence that Hib
infection could be divided into three elements: nasopharyngeal colonization, bacteremia,
and central nervous system (CNS) invasion. In 1978, by intranasally inoculating the
neonatal rats with mixtures of otherwise isogenic streptomycin sensitive and resistant
strains of H. influenzae, SmS and SmR, and tracking the development of bacteremia
and meningitis, Moxon and Murphy found that, five minutes after inoculation, both
variants were found in the blood. In contrast at 54 hours, nearly 70% of rats had
pure SmS or SmR in the blood (Figure 1) and cerebrospinal fluid, and the cultures
had SmS and SmR isolated in nearly equal frequency [3]. Their observation that the
primary infections (nasal colonization and early blood flora for Hib) are diverse, while
mature infections (blood after > 10 hrs for Hib) were monoclonal is known as the single-
variant bottleneck. The bottleneck is not unique to Hib. In fact, it was discovered first
by Meynell in Salmonella typhimurium infections in mice [4]. And similar observations
have been reported in experimental studies of other host-bacteria [5, 6, 7] and host-virus
[8, 9, 10, 11, 12, 13, 14] interactions.
Models of the infection process must be able to explain the single-variant bottleneck,
and also the fact that, although there are high frequencies of people colonized with
virulent strains of H. influenzae as carriers, only minority of hosts (e. g., children under
5 [3, 1]) manifest invasive infections even for the most virulent strains of these bacteria.
Three classes of possible explanations have been proposed: stochasticity resulting from
independent action of bacteria [4, 15, 16, 17, 18], variations in host susceptibility, and
the emergence of bacterial mutants (known as within-host evolution) [19, 20, 21]. The
original theory of independent action was proposed by Druett in 1952 [22]. It assumed
that each individual bacterial cell has an independent probability to colonize the host,
and that an infection can start from a single random bacterium, hence explaining the
bottleneck. Meynell and Stocker later provided experimental evidence consistent with
the theory of independent action [4] and inconsistent with an alternative: synergistic or
cooperative action. However, in its simple form, independent action could not explain
why a variant present in the blood five minutes post-inoculation can no longer be
detected a few hours later. Host susceptibility could only explain the high infection
rate in young children over adults, but not the experimental observation of the presence
of both variants in the bloodstream only very early post-inoculation stage [3]. Finally,
to test the within-host evolution hypothesis, Margolis and Levin performed additional
H. influenzae experiments with neonatal rats. They compared the invasiveness and the
re-colonization potential of the variant surviving in the bloodstream and the remaining
variant staying in nasopharynx [21]. In five out of six clones examined, they observed
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Figure 1. Moxon and Murphy’s experimental data. Replotted from [3]. 120
neonatal rats were infected at each inoculum size, which ranged from 104 to 108
bacteria, equally mixed from streptomycine susceptible strain, SmS , and streptomycine
resistant strain, SmR. Blood of the rats was then harvested and cultured. All cultures
that produced both SmS and SmR colonies were called mixed infections. All cultures
that produced 8 or more colonies of one strain and none of the other were called
pure infections (there was no statistically significant difference in the abundance of
pure SmS or pure SmR cultures). Cultures that produced no colonieshown on the
plots, or produced colonies of one strain only, but fewer than 8 of those, were called
indeterminate. Most infections ended up as pure (single-variant) infections 54 hours
post-inoculum. Samples taken within 5 and 30 minutes post-inoculum were mixed
(data not show on the plot), see Ref. [3]). Error bars denote the usual square-root
counting errors. Over four orders of magnitude in the inoculum size, preponderance
of indeterminate infections declined somewhat, from ∼80% to ∼40%. Over the same
range of the inoculum, mixed infections increased from <1% to ∼20%.
no difference in the ability of bacteria isolated from the blood to outcompete those
remaining in the nasopharynx during re-infection. This result suggested that within-
host evolution is not the dominant explanation for the Moxon-Murphy observations.
During the last two decades it has become clear that bacteria can switch phenotypic
states without any changes in their genomes [15, 17, 23, 24, 25, 26, 27]. This provides an
alternative hypothesis to explain the Moxon-Murphy results. First, a single bacterium of
one strain can randomly switch into a faster growing phenotype or a more invasive state.
Then the host immune system, activated by the infection emerging from the switched
bacterium, acts against both strains and clears the clone that has not phenotypically
switched and thus grows slowly. In other words, the first successfully switching cell in
one strain will interact with the host immune response to ‘shut the door’ on the other
strain and thereby explain the single-variant bottleneck and the subsequent failure to
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isolate genetically more invasive clones from the blood [21].
This stochastic switching mechanism together with the immune response has
been mentioned frequently as a possible explanation for the bottleneck phenomenon
in various presentations and discussions. Nevertheless, we have been unable to find
a detailed theoretical or experimental analysis of this process in the literature. We
call this phenotypic switching mechanism followed by immune-facilitated clearance
of the competing strain the colloquial hypothesis. Our goal here is to analyze the
colloquial hypothesis quantitatively and to explore the condition under which it can or
cannot rescue the theory of independent action as the explanation of the single-variant
bottleneck in early bacteremia.
In the following sections, we will develop a mathematical model of the colloquial
hypothesis applied to the early stages of Hib bacteremia inoculated with two variants of
equally invasive bacteria. We will show that the model, as well as its simple extensions,
cannot provide a quantitative explanation for the experimental data [3, 20, 21, 28], and
namely the observed weak dependence of the rate of different types of infections on the
inoculum size. We argue that, to provide even a semi-quantitative fit to the data, we
must assume that various rate parameters describing the infection scale sublinearly with
the inoculum size, so that the probability per bacterium to start an infection decreases
when other bacteria are present. This means further evidence for abandoning the theory
of independent action.
2. Hypothesis and Model
Inspired by demonstration of phenotypic switching in bacteria [17, 24, 25, 26, 27, 29,
30, 31], we propose that each individual bacterial cell of both variants A and B has two
phenotypes relevant for the early infection. The first is the “crossing” phenotype (C),
which allows bacteria to cross the physical barrier between the nasopharynx and blood,
but does not exhibit strong growth in the bloodstream [32, 33, 34]. The second is the
“growing” phenotype (G), with cells that grow fast in the bloodstream, but cannot cross
into the bloodstream. After a bacterium crosses into the bloodstream, it can switch to
the G state, but the switching C→G is stochastic and rare. In this work, we are not
concerned with the mechanisms underlying the existence of these two states and of
switching between them, but only focus on consequences of the switching.
Once bacterial cells enter the bloodstream, immune response is activated. To model
the immune response in the early stages of bacteremia, we assume that neonatal rats
only have innate immunity, which is non-specific and responds as soon as the bacterial
cells emerge in the blood [1, 3, 19, 35]. In other words, there is no clonal expansion, and
instead there is a finite reservoir of immune cells that can be recruited to the infection
site linearly until the reservoir is depleted [35].
These assumptions are represented in the following ordinary differential equations
(ODEs) describing the growth of bacterial cells of variant A and the immune cell
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recruitment:
dAC
dt
= gCAC
(
1− Ntotal
N0
)
− γCIAC − dAC + j, (1)
dAG
dt
= gGAG
(
1− Ntotal
N0
)
− γGIAG − dAG, (2)
dI
dt
= rC(I0 − I)(AC +BC) + rG(I0 − I)(AG +BG)− dII. (3)
The growth of the bacterial strain B is described by equations similar to Eqs. (1, 2),
with letters A replaced by B.
In the equations describing bacterial population dynamics, Eqs. (1, 2), gC and gG
are the growth rates of the crossing and the growing phenotypes, respectively (same
for variants A and B since both variants are equally virulent [3, 21]). For simplicity,
in what follows we set gC = 0. Ntotal is the total number of bacteria in the blood,
Ntotal ≡ AC +AG+BC +BG. N0 is the carrying capacity, the maximum of the bacterial
population in the bloodstream, so that N0 ≥ Ntotal. γC and γG are the bacterial death
rates due to the elimination by the immune cells, and d is the natural cell death. Finally,
j is the flux of the crossing phenotype cells from the nasopharynx to the bloodstream per
unit time. To satisfy the hypothesis of independent action, it is assumed to be linearly
proportional to the inoculum size S, so that j = αjS, where αj is some constant.
Equation (3) describes the immune cells recruitment. Here rC and rG are the
recruitment rates due to effects of the bacterial phenotypes [35]. I0 is the total number
of available innate immune cells in the host. dI is the death rate, or deactivation rate of
immune cells. Parameters in Eq. (3) are determined up to a scale. Thus we set I0 = 1,
which redefines the scale of I and also renormalizes γC and γG in Eqs. (1, 2). To simplify
the model, we set γC = γG = γ, and rC = rG = r.
To finish specifying the model, we assume for now that the switching from C to G is
a single step stochastic transition at a low per-bacterium rate ρ. Since the switching is
single-step, the waiting time to the switch is exponentially distributed for each cell.
Further, if the independent action hypothesis is valid, then for AC bacteria in the
crossing phenotype, the probability of having k individuals of type A switching to the
growing state per time ∆t is given by the Poisson distribution:
P (k|AC) = (ρAC∆t)
ke−ρAC∆t
k!
. (4)
A similar distribution determines the switching probability for the B strain. We do not
consider switching back from the G to the C state.
We simulate the model using the Euler method to solve its ODEs, Eqs. (1, 2,
3) and their equivalents for the B strain. Further, at every time step, we generate a
random number of switching individuals using Eq. (4) for the A and the B strain. If the
number of cells in any strain / phenotypic state combination falls below one, we set it
to zero to account for the discreteness of the bacteria. While this combined stochastic-
deterministic simulation scheme is certainly not the most accurate, we feel that it offers
the precision necessary for our analysis. It certainly is capable of discovering the salient
Single−variant bottleneck in bacteremia 6
qualitative features of the models that we investigate. Further, it is much faster that
fully stochastic simulations schemes, which is important since the model must be solved
repeatedly in optimization steps. Finally, statistical properties of Hib bacterial division
are not well understood; thus building a fully stochastic model of the system, including
modeling the divisions as first order, memoryless reactions, would be not any more
accurate than neglecting the stochasticity altogether.
3. Results
3.1. The colloquial model
We illustrate a possible dynamics of the colloquial model in Fig. 2 for the first 60 hours
post-inoculum in an individual rat with a certain set of model parameters. In this case,
a cell of strain B switched to the growing phenotype first at t ≈ 11 hrs. Then the
rapid growth of BG accelerated the recruitment of immune cells. In their turn, the
immune cells nearly wiped the population of the non-switched strain A, transforming
the infection into the pure B infection about 30 h post-inoculation. Therefore, even
though cells act independently, they interact through the immune response, and the
first variant to have a switcher wins the competition. This example illustrates that the
colloquial hypothesis may have a potential to explain the single-variant bottleneck in
the early stages of bacteremia.
To test the suitability of the colloquial model quantitatively, we calculate and
maximize its likelihood given the observed experimental data. As in the Moxon and
Murphy experiment, we assume the multinomial structure of the data with three possible
outcomes: pure infection, mixed infection, and indeterminate infection. Recall that
Moxon and Murphy plated blood samples from their rats and counted the number of
colonies of each strain that grew as a result. They defined any culture with colonies of
both strains (even if one of the strains had as few as one colony) as a mixed infection. A
pure infection was defined more stringently, so that there had to be at least eight colonies
of one strain and none of the other to qualify. All other cases were deemed indeterminate.
In our simulations, accounting for dilution at plating, we estimate that a mixed infection
would require both bacterial strains present at a level of 100 cells/ml of bacteria or more,
and a pure infection would require at least 800 cells/ml of bacteria of one type and less
than 100 cells/ml of the other. To calculate the likelihood of the data given a set of
parameters, we simulate infections using our mixed stochastic-deterministic simulations.
We repeat this 200 times to estimate the multinomial probabilities. We then write down
the multinomial likelihood of the experimental data given the frequencies defined by
the numerical simulations. Finally, we optimize the model over the parameters using
patternsearch from Matlab with GPS Positive basis Np1 as the poll method. This
routine allows optimization of stochastic functions. The optimization is performed at
least three times from different initial conditions, and we report the best fit model as
the one maximizing the likelihood over all such optimization runs.
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Figure 2. Simulation of early bacteremia resulting in a pure infection in an
individual rat. Simulations were done with the following parameters: inoculum size
S = 105; switching rate ρ = 4.5 · 10−5 h−1; growth rates gC = 0, gG = 1 h−1; immune
recruitment rates r = 6.1 · 10−6 h−1; rate at which immune cells kill bacteria γ = 0.75
h−1; carrying capacity of the blood N0 = 108 cells; flux from the nasopharynx to blood
αj = 4.3 · 10−4 h−1; natural death rate of bacteria and immune cells d = 0.01 h−1
and dI = 0.02 h
−1. In this realization, variant B has the first switch from C to G
at about 11 hours and establishes bacteremia. The panels show the population size
of the crossing and the growing phenotypes of A and B strains, the fraction of the
immune response activated, and the total infection size. Notice that the vertical axes
in different panels have different scalings.
The experimental data that we fit contains five different inoculum sizes, and three
possible outcomes at 54 hrs post inoculation (for a total of 10 independent data points
since the frequencies at each inoculum sum to one). In addition, the experimental data
contains measurements a few minutes after inoculation for each inoculum size (10 more
independent data points), at which point every infection was mixed. Note that these
data are not time series—every rat could be analyzed only once—so that the data at
different time points are independently multinomially distributed.
These 20 data points must be explained by 8 independent parameters: αj, gG, d,
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N0, r, γ, dI , and ρ. This may sound like an easy fitting problem. However, it turns out
that the requirement of having all mixed infections soon after inoculation, and a lot of
pure infections later on is not easy to satisfy. Thus we do not perform formal analysis
of the quality of fit / overfitting in this and the other models we try: the difficulty to fit
the data makes most models obviously poor, and differences among the quality of fits
of various models are clear without formal analyses.
The optimization is further constrained since biologically realistic limits exist on
the model parameters. First, all of the parameters are positive. Further, an upper limit
on N0 is about ∼ 2 ·109 cells/ml [36], while its lower limit is determined by the fact that
Moxon and Murphy observed ∼ 1×104 or more cells/ml in the bloodstream of neonatal
rats with severe infections [3]. The growth rate of Hib in synthetic blood culture was
studied in [36], which provides the initial guess and upper limit of gG between 0.4 to 1.2
per hour. We could not find any data in the literature regarding the parameters of the
innate immune response to Hib. However, some data is available for Listeria infection
[37, 38], which allowed us to choose initial conditions of the immune response for the
optimization: r ∼ 1 · 10−6 h−1 cells−1, γ ∼ 0.1 h−1, dI ∼ 0.02 h−1.
Two of the best quantitative fits of the colloquial model are shown in Fig. 3. Some of
the parameters of these fits are physiologically unrealistic, but even this does not help:
none of the fits are good. The main difficulty seems to be that keeping the fraction
of pure / indeterminate infections nearly constant over four orders of magnitude of
the inoculum size, S, especially following a mixed infection soon after inoculation, is
impossible within this independent action model. Indeed, the fit in the left panel keeps
pure infections at nearly zero frequency in order to have few mixed infections. Similarly,
in the right panel, which does a better job in fitting the frequency of pure infections,
the mixed infections rate spikes to 100% at high S. Note parenthetically that the non-
monotonicity of the mixed infection line in this figure is because of the linearly increasing
flux j interacting with the immune system. When S = 104 and 105, the flux is small,
and infections do not start. When S = 106 and 107, both of the strains A and B
have more than 100 bacteria of the crossing phenotype in the blood even if none of the
cells switches, resulting in a mixed infection according to our definitions. At S = 107,
switching starts happening often, resulting in a faster activation of the immune response
and clearance of the non-switched strain. Finally, when S = 108, both strains are in
large enough numbers to switch early on and at about the same time, resulting in mixed
infections again, but now in the growing phenotypes.
One can modify the model to make it fit better. Since rats have mucosal immunity
[39, 40, 41, 42, 43], one can hope that bacteria in the nasopharynx will be eventually
cleared as well. The simplest way of modeling this is to say that the flux from the
nasopharynx into the bloodstream has a finite duration tj, which itself is an unknown
variable that needs to be fitted. Further, we notice that the natural (not caused by the
immune system) death rate of bacterial cells and the death rate of immune cells in the
fits in Fig. 3 are very small. Hence, to not simplify fitting with the introduction of the
new time parameter, we set both of these parameters to zero (we verified that the fits
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Figure 3. Maximum likelihood fits of the colloquial model. We show two
different local maxima in the parameter space with nearly equivalent likelihoods.
Neither set of parameters provides good fits. In this and subsequent figures, error bars
on model predictions are given by standard deviations of results from 200 simulations.
For the parameter values in the left panel (ρ ≈ 1.7·10−5h−1, gG = 1.0 h−1, r ≈ 6.1·10−6
h−1 cells−1, γ ≈ 240 h−1, N0 ≈ 1.8 · 109 cells, αj ≈ 4.5 · 10−5 h−1, d ≈ 7.2 · 10−4 h−1,
dI ≈ 1.7 · 10−6 h−1), infections do not establish until very large inoculums. For the
right panel (ρ ≈ 1.7 · 10−5 h−1, gG = 1.0 h−1, r ≈ 4.1 · 10−8 h−1 cells−1, γ ≈ 30.5 h−1,
N0 ≈ 1.2 · 108 cells, αj ≈ 1.2 · 10−5 h−1, d = 0.01 h−1, dI = 0.018 h−1), the need to
establish pure infections over the four orders of magnitude in the inoculum size leads
to a large number of mixed infections as well.
do not improve dramatically when this condition is relaxed). The optimized fit for this
model is shown in Fig. 4. The fit is clearly better than in Fig. 3, but it is still poor:
to have pure infections at medium/high inoculums, the independent action hypothesis
still requires no (or indeterminate) infections at small inoculums.
The key problem of the colloquial model is the experimentally observed weak
dependence of the fractions of various infection types on the inoculum size. In other
words, in these simple models, independent action means that the number of cells that
attempt C→G switching in the blood scales with S. Thus the time to the first such
switch would scale as 1/S. If the switch happens in the bulk of the 54 h experiment
duration, an infection is established. Thus it is very hard to devise an independent
action model that would have a non-negligible number of switches over 54 hrs at small
inoculums, S = 104, and yet would not have switches happening 100% of the time at
large inoculums, S = 108. The model must be modified so that the mean time to the
first switch decreases slower than 1/S.
Interestingly, there is a straightforward biologically realistic modification of the
model that achieves this. In many cases, the process of bacterial phenotypic switching
is not determined by a one-step chemical reaction, but proceeds through a series of
roughly equally slow steps. For example, the switching of E. coli to express PAP genes
and become virulent [44, 45] can be modeled as a four-step reaction [33]. Such n-step
activation ensures that the probability distribution of time to the complete switch in
an individual bacterium goes as ∝ tn−1 for small t [46, 47]. Then for ∝ S bacteria, the
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Figure 4. Maximum likelihood fits of the colloquial model with the limited
time duration of the bacterial flux from the nasal cavity to the bloodstream.
Natural bacterial cell death rate and immune cell death rate are set to zero. The
duration of the flux is a fixed value for all inoculum sizes, tj ≈ 4.1 h. Other optimized
parameters are: ρ ≈ 3.5 · 10−5 h−1, gG ≈ 0.96 h−1, γ ≈ 2.0 h−1, r ≈ 2.1 · 10−7 h−1
cells−1, N0 ≈ 1.0 · 106 cells, αj ≈ 1.4× 10−5 h−1.
expected time till the first of them switches is governed by the Weibull distribution,
resulting in Stn−1 ∝ 1, and t ∝ 1/S1/(n−1) [47]. In other words, the time to the first
bacterium in a large population switching scales sublinearly with the inverse population
size, offering a potential opportunity to explain the weak dependence on the inoculum
size.
We implement and optimized this model in numerical simulations by introducing
a series of phenotypic transitions C→G1 → . . . →Gn, where only the last state, Gn,
grows fast, and the rest of the states share the growth/death rates with C. Random
switching between the subsequent states was again governed by the Poisson dynamics,
as in Eq. (4). We explored n = 2, 3, 4. Fig. 5 shows results of the optimization, where
n = 3 (empirically best choice), and all transition rates in the chain C→G1 →G2 →G3
were the same (which results in the most sublinear dependence of the switch time on S).
Further, since in this model switching takes extended time, the first bacteria to cross
over to blood from the nasopharynx will be the ones switching, and hence it makes
little difference for the switching statistics if the flux has a limited duration. At the
same time, stopping of the flux into the blood results in a lower concentration of the
non-switched strain, making it easier to develop pure infections at 54 hrs. Therefore, we
inherit the value tj ≈ 4.1 hrs from the 1-step model. Clearly, the quality of fit improves
dramatically compared to the 1-step model, and yet the fits are still far from perfect:
mixed and pure infections go hand-in-hand, and to have no mixed infections at S = 104
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requires having no infections at all at this inoculum. This illustrates a fundamental
problem of the multi-step switching mechanism: while the time to a switch, indeed,
scales sublinearly with 1/S, the standard deviation of this time falls off very quickly,
making the switching nearly deterministic [47]. Thus both strains switch at about the
same time, and typically either both develop into an infection (mixed outcome) or none
does (indeterminate outcome).
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Figure 5. Maximum likelihood fits for the colloquial model with the limited
bacterial flux duration and three-step switching. Natural bacterial cell death
rate and immune cell death rate are set to zero. The duration of the flux is a fixed
value for all inoculum sizes, tj ≈ 4.1 h. Optimized parameter values are ρ ≈ 0.0014
h−1, gG ≈ 1.1 h−1, γ ≈ 9.7 h−1, r ≈ 1.1 · 10−7 h−1 cells−1, N0 ≈ 1.0 · 109 cells,
αj ≈ 3.4 · 10−4 h−1.
In summary, the independent action model, even augmented by multi-step switching
and finite bacterial flux duration, seems to be incapable of explaining the observed
experimental data.
3.2. Beyond the independent action model
The independent action hypothesis is implemented in our model, in part, by an
assumption that the bacterial flux from the nasopharynx to blood is proportional to
the inoculum size, S. We consider multiple extensions of the colloquial model that
break this assumption.
First, we tried the model where the flux is independent of S, j = αj, which must
be optimized. However, then the flux duration scales nonlinearly with S, tj = αtS
bt .
The logic behind this model is that there might be purely physical constraints on how
many bacteria can cross the tissues between the two body compartment per unit time,
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and this bandwidth can be saturated even at moderate inoculums. At the same time,
it could take the mucosal immunity a longer time to clear a larger inoculum. We retain
the 1-step switching model, because the higher variability of the switching time within
this model allows for easier establishment of pure infections. The maximum likelihood
results are shown in Fig. 6. While imperfect, the fits are surprisingly good, able to
sustain pure, mixed, and indeterminate infections over the entire range of S. However,
bt ≈ 0.1 is very small, so that the duration of the bacterial flux is maximally ∼ 3 hours,
which makes it hard to imagine physiological mechanisms that would create it.
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Figure 6. Maximum likelihood fits for the non-independent action model
with the S-dependent flux duration. The fitted model has j = αj = const,
and tj = αtS
bt . This model provides much better fits than all of the variants of the
independent action model we have tested. The optimized parameters are ρ ≈ 6.1 ·10−6
h−1, gG ≈ 0.55 h−1, N0 ≈ 1.0·107 cells, γ ≈ 2.0 h−1, r ≈ 2.3·10−6 h−1 cells−1, αt ≈ 0.5
h−1, bt ≈ 0.1, αj ≈ 3.3 · 103 h−1.
Another way to model non-independent action is the model where the duration of
the bacterial flux tj is fixed and independent of S, but j = αjS
bj . Optimized dynamics
for this model is shown in Fig. 7, providing clearly the best fit to the experimental data
of the ones we have seen so far. Interestingly, the fitted values of the parameters in this
model are biologically realistic, resulting, for example, in bacterial fluxes of 102 ∼ 103
cells/h, and tj ≈ 34 hrs, longer than 1 day.
4. Discussion
In this investigation, we built mathematical models of the early Hib stages of infections
started by a culture with two equally invasive strains. The models have to account
for the following broad observations: (1) both strains are present in the blood soon
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Figure 7. Maximum likelihood fits for the non-independent action model
with the sublinear dependence of the magnitude of the bacterial flux on S.
We use j = αjS
bj with a fixed tj . The optimized parameters are: ρ ≈ 5.7 · 10−6 h−1,
gG ≈ 1.0 h−1, γ ≈ 3.2 h−1, r ≈ 3.1 · 10−6 h−1 cells−1, N0 ≈ 1.0 · 106 cells, αj ≈ 7 h−1,
bj ≈ 0.37, and finally tj ≈ 34.0 h, which is essentially equivalent to saying that the
bacterial flux is temporally unconstrained.
after inoculation into nasal passages; (2) both strains are either cleared from the blood
within 54 hrs post inoculation, or are equally likely to be responsible for monoclonal
bacteremias; and (3) the weak dependence of the likelihood of invasive infections on
the inoculum size, i. e., a few-fold difference in the likelihood of bacteremia for a 104-
fold change in the size of the inoculum. The colloquial hypothesis tries to explain
these effects as variations on the theme of independent action of bacteria in establishing
infections. In such explanations, one commonly augments the independent action by
stochasticity of phenotypic transitions and by interactions with the immune system. In
this interpretation, both bacterial clones inoculated into the nasal passages cross into
the bloodstream, at which point one individual randomly switches into a more invasive
phenotype and activates the immune system. The immune system then clears the non-
switched strain, resulting in monoclonal infections.
We analyzed this colloquial hypothesis quantitatively, starting with its simplest
realization. Further, we considered additional variants that involved more complex (and
hence statistically different) switching between the crossing and the growing phenotypes,
or effects of mucosal immunity, which can clear the nasopharyngeal infection and stop
bacterial flux into the bloodstream a few hours into the experiment. None of these
modifications proved sufficient to explain the experimental data, and, in particular, to
account for the weak dependence of the likelihood of the infections on the inoculum
size. In contrast, when we forwent the independent action assumption and allowed
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the flux of bacteria into the bloodstream to depend sublinearly on the inoculum
size, the fits to the data became very good. Thus our analysis suggests that the
hypothesis of independent action may be violated in the case of early establishment of
bacterial infections. Note that classic investigations of independent action [4] tested the
hypothesis against synergistic effects. Here we argue that the non-independent action
effects are redundant—the probability of a single bacterium to establish an infection
decreases with the inoculum size. This is surprising, and certainly goes against ideas
in the quorum sensing literature [48], where an infection is established synergistically
when the number of bacteria crosses a certain minium density threshold.
Our best model suggests that the flux of bacteria from the nasopharyngeal
inoculation to the bloodstream scales as the inoculum size to the∼ 0.37 power. The data
that we have been able to find in the literature is not sufficient to provide an empirical
basis for the mechanism of this scaling: the physical structure of the animal tissues
and bacterial colonies, the fluid dynamics of the bacterial culture in the nasopharyngeal
cavity, interactions of bacteria with the immune system, or interactions of bacteria
among themselves could all play a role. The closeness of the exponent to 1/3 is
also interesting, suggesting that maybe a certain modification of the 3-step stochastic
switching model, similar to that studied in Fig. 5, could play a role as well.
While informative at some level, negative results alone rarely appear in publications
nowadays [49]. Beyond obvious social pressures, there are functional reasons for this as
well: one can never be sure that the negative result is meaningful, rather than due to not
trying hard to find a positive agreement between a hypothesis and data. For example, in
our study, we cannot be sure that we have explored the parameter space well enough, and
that we have tried all simple, reasonable modifications to the original colloquial model to
argue that the independent action theory cannot explain the data. We can only say with
certainty that we have not been able to reconcile the independent action theory with the
data. It will require additional experimental and theoretical investigations to understand
if and under which conditions the independent action hypothesis is, indeed, violated in
early infections. The model proposed here would suggest that the bacterial concentration
in the blood soon after inoculation should scale sublinearly with the incoculum size,
which is relatively straight forward to check experimentally. Further, repeating the
experiments in immune compromised rats, with no innate immunity, should result in no
pure infections even at small inoculums. Moreover, due to the sublinear dependence,
the probability of transmission of the disease among individuals should depend weakly
on the strength of the infection in an infected host, which is bound to have public health
implications, and is also experimentally testable. We hope that our study will spur such
future investigations, in Hib and in other infections.
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